对PI3Kα酶与选择性抑制剂结合的量子生物化学描述
Francisca Joseli Freitas de Sousa1, Francisca Fernanda Nunes Azevedo1, Francisco Lucas Santos de Oliveira2
1Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Brazil.
Journal of biomolecular structure & dynamics
|August 26, 2023
概括
这项研究研究了选择性抑制剂如何与PI3Kα结合,PI3Kα是癌症的关键标. 通过识别关键的结合热点,了解这些分子相互作用有助于设计更有效的癌症药物.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 计算化学的计算化学
背景情况:
- 酸3-酶 (PI3K) 类I酶调节细胞中的重要过程.
- PI3Kα的过度活化与各种癌症有关,导致预后不佳.
- 由于保留了ATP结合口袋,开发选择性PI3K异型抑制剂具有挑战性.
研究的目的:
- 为了研究控制阿尔佩利西布和GDC-0326与PI3Kα ATP结合口袋的结合的分子特征.
- 为了确定关键的氨基酸残留物和对选择性抑制剂结合至关重要的相互作用.
- 为新型PI3Kα向剂的合理设计提供见解.
主要方法:
- 分子动力学模拟来放松蛋白质结构.
- 量子计算使用分子分离与结合式帽子方案和密度函数理论 (DFT).
- 对于有约束和无约束状态的连接体的原子电荷的计算.
主要成果:
- 确定了阿尔佩利西布结合的主要残留物:Ile932,Glu859,Val851,Val850,Tyr836,Met922,Ile800和Ile848.
- 确定了GDC-0326结合的主要残留物:Ile848,Ile800,Ile932,Gln859,Glu849和Met922.
- 两种抑制剂的共同热点残留物 (Trp780,Ile800,Tyr836,Ile848,Gln859,Val850,Val851,Ile932,Met922) 得到了突出显示.
结论:
- 这项研究阐明了PI3Kα抑制剂选择性的基础分子机制.
- 确定了可以指导新型选择性PI3K抑制剂合理设计的关键相互作用.
- 有助于开发更有效的向癌症治疗方法.
相关概念视频
Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Enzyme Inhibition
78.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.7K
IP3/DAG Signaling Pathway
12.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.2K


